Cytarabine and daunorubicin liposomal and LidoSite

• Generic Name: cytarabine liposomal / daunorubicin liposomal
• Dosage Forms: n.a.
• Other Brand Names: Vyxeos

Cytarabine and daunorubicin are cancer medicines that interfere with the growth and spread of cancer cells in the body.

Cytarabine and daunorubicin liposomal is a combination medicine used in adults to treat acute myeloid leukemia that is newly diagnosed.

Cytarabine and daunorubicin liposomal may also be used for purposes not listed in this medication guide.

• Generic Name: epinephrine / lidocaine
• Dosage Forms: Topical Iontophoretic Patch and Controller
• Other Brand Names: D-Care 100X, Lignospan Forte, Lignospan Standard, Xylocaine MPF With Epinephrine, Xylocaine With Epinephrine

LidoSite uses an active transdermal delivery technology known as iontophoresis, which administers medications through the skin via a mild electric current. The LidoSite system administers lidocaine and epinepherine using a patented electrotransport technology that enables the controlled delivery of medication over a predetermined period of time, from minutes to days. Topical anesthetic creams and patches can take up to an hour to numb the skin, while LidoSite works in 10 minutes. LidoSite has successfully completed clinical trials and has been found to significantly decrease pain from needle injections and similar procedures in both adults and children. Lidosite is intended to also address a strong need in adult applications. Its major impact is expected to be in the pediatric population, where pain associated with needlesticks, blood-draw procedures and immunizations is a major issue for the clinician, child and parent.